SKYEPHARMA'S FORADIL GETS GERMAN APPROVAL

SkyePharma on Monday said German regulators approved its Foradil Certihaler treatment for asthma and chronic obstructive pulmonary disease, making Germany the sixth European country to green-light the drug. Chronic obstructive pulmonary disease causes frequent coughing due to excess mucus produced by the lungs. SkyePharma and co-developer Novartis Pharma AG have been seeking regulatory approval for the treatment in Europe on a country-by-country basis since 2002.

Forbes (http://www.forbes.com/technology/sciences/feeds/ap/2005/06/20/ap2101735.html)